Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Ribelli

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biomedicines|September 23, 2022
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell ProliferationMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Frontiers in Oncology|December 30, 2021
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent MechanismsGiulia Ribelli, Sonia Simonetti, Michele Iuliani, et al.
Frontiers in Oncology|June 26, 2020
Current and Emerging Biomarkers Predicting Bone Metastasis DevelopmentMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Biology|August 27, 2021
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell CarcinomaMichele Iuliani, Sonia Simonetti, Francesco Pantano, et al.
Scientific Reports|January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerFrancesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
Critical Reviews in Oncology/Hematology|March 23, 2017
Determinants of bone specific metastasis in prostate cancerPaolo Manca, Francesco Pantano, Michele Iuliani, et al.
International Journal of Molecular Sciences|March 10, 2022
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone MicroenvironmentMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Expert Opinion on Emerging Drugs|June 27, 2015
Emerging drugs for the treatment of bone metastasisFrancesco Pantano, Michele Iuliani, Alice Zoccoli, et al.
Breast Cancer Research : BCR|September 3, 2015
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidenceDaniele Santini, Luciano Stumbo, Chiara Spoto, et al.
Oncotarget|February 23, 2017
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functionsMarco Fioramonti, Daniele Santini, Michele Iuliani, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomedicines|September 23, 2022
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell ProliferationMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Frontiers in Oncology|December 30, 2021
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent MechanismsGiulia Ribelli, Sonia Simonetti, Michele Iuliani, et al.
Frontiers in Oncology|June 26, 2020
Current and Emerging Biomarkers Predicting Bone Metastasis DevelopmentMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Biology|August 27, 2021
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell CarcinomaMichele Iuliani, Sonia Simonetti, Francesco Pantano, et al.
Scientific Reports|January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerFrancesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
Critical Reviews in Oncology/Hematology|March 23, 2017
Determinants of bone specific metastasis in prostate cancerPaolo Manca, Francesco Pantano, Michele Iuliani, et al.
International Journal of Molecular Sciences|March 10, 2022
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone MicroenvironmentMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Expert Opinion on Emerging Drugs|June 27, 2015
Emerging drugs for the treatment of bone metastasisFrancesco Pantano, Michele Iuliani, Alice Zoccoli, et al.
Breast Cancer Research : BCR|September 3, 2015
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidenceDaniele Santini, Luciano Stumbo, Chiara Spoto, et al.
Oncotarget|February 23, 2017
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functionsMarco Fioramonti, Daniele Santini, Michele Iuliani, et al.
Pageof 2